Activation and inhibition of human muscular and neuronal nicotinic acetylcholine receptors by succinylcholine

Anesthesiology

Volumn 104, Issue 4, 2006, Pages 724-733

  Jonsson, Malin ^a   Dabrowski, Michael ^b   Gurley, David A ^c   Larsson, Olof ^b   Johnson, Edwin C ^c   Fredholm, Bertil B ^d   Eriksson, Lars I ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c ASTRAZENECA   (United Kingdom)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AUTORECEPTOR; LIGAND; MESSENGER RNA; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3BETA2; NICOTINIC RECEPTOR ALPHA3BETA4; NICOTINIC RECEPTOR ALPHA4BETA2; NICOTINIC RECEPTOR ALPHA7; NICOTINIC RECEPTOR BLOCKING AGENT; PRESYNAPTIC RECEPTOR; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; SUXAMETHONIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTONOMIC GANGLION; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; DRUG MECHANISM; ELECTRODE; FEMALE; HUMAN; IC 50; INHIBITION KINETICS; MEMBRANE POTENTIAL; MUSCLE; NERVE; NEUROMUSCULAR BLOCKING; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; TACHYCARDIA; VOLTAGE CLAMP; XENOPUS LAEVIS;

ACETYLCHOLINE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MUSCLES; NEUROMUSCULAR DEPOLARIZING AGENTS; NEURONS; PROTEIN SUBUNITS; RECEPTORS, NICOTINIC; SUCCINYLCHOLINE; XENOPUS LAEVIS;

EID: 33645650003     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200604000-00017     Document Type: Article

References (49)

1. Lukas RJ, Changeux JP, Le Novere N, Albuquerque EX, Balfour DJ, Berg DK, Bertrand D, Chiappinelli VA, Clarke PB, Collins AC, Dani JA, Grady SR, Kellar KJ, Lindstrom JM, Marks MJ, Quik M, Taylor PW, Wonnacott S: International Union of Pharmacology: XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol Rev 1999; 51:397-401
2. Gotti C, Clementi F: Neuronal nicotinic receptors: From structure to pathology. Prog Neurobiol 2004; 74:363-96
3. Schuetze SM, Role LW: Developmental regulation of nicotinic acetylcholine receptors. Annu Rev Neurosci 1987; 10:403-57
4. Salpeter MM, Marchaterre M, Harris R: Distribution of extrajunctional acetylcholine receptors on a vertebrate muscle: Evaluated by using a scanning electron microscope autoradiographic procedure. J Cell Biol 1988; 106:2087-93
5. Lindstrom JM: Nicotinic acetylcholine receptors of muscles and nerves: Comparison of their structures, functional roles, and vulnerability to pathology. Ann N Y Acad Sci 2003; 998:41-52
6. Hogg RC, Raggenbass M, Bertrand D: Nicotinic acetylcholine receptors: From structure to brain function. Rev Physiol Biochem Pharmacol 2003; 147:1-46
7. Iturriaga R, Alcayaga J: Neurotransmission in the carotid body: Transmitters and modulators between glomus cells and petrosal ganglion nerve terminals. Brain Res Brain Res Rev 2004; 47:46-53
8. Wessler I: Control of transmitter release from the motor nerve by presynaptic nicotinic and muscarinic autoreceptors. Trends Pharmacol Sci 1989; 10:110-4
9. Bowman WC, Prior C, Marshall IG: Presynaptic receptors in the neuromuscular junction. Ann N Y Acad Sci 1990; 604:69-81
10. Faria M, Oliveira L, Timoteo MA, Lobo MG, Correia-De-Sa P: Blockade of neuronal facilitatory nicotinic receptors containing alpha 3 beta 2 subunits contribute to tetanic fade in the rat isolated diaphragm. Synapse 2003; 49:77-88
11. Tsuneki H, Kimura I, Dezaki K, Kimura M, Sala C, Fumagalli G: Immunohistochemical localization of neuronal nicotinic receptor subtypes at the pre- and postjunctional sites in mouse diaphragm muscle. Neurosci Lett 1995; 196:13-6
12. Bibevski S, Zhou Y, McIntosh JM, Zigmond RE, Dunlap ME: Functional nicotinic acetylcholine receptors that mediate ganglionic transmission in cardiac parasympathetic neurons. J Neurosci 2000; 20:5076-82
13. Hogg RC, Miranda LP, Craik DJ, Lewis RJ, Alewood PF, Adams DJ: Single amino acid substitutions in alpha-conotoxin PnIA shift selectivity for subtypes of the mammalian neuronal nicotinic acetylcholine receptor. J Biol Chem 1999; 274:36559-64
14. Paterson D, Nordberg A: Neuronal nicotinic receptors in the human brain. Prog Neurobiol 2000; 61:75-111
15. Goedde HW, Held KR, Altland K: Hydrolysis of succinyldicholine and succinylmonocholine in human serum. Mol Pharmacol 1968; 4:274-87
16. Ostergaard D, Engbaek J, Viby-Mogensen J,: Adverse reactions and interactions of the neuromuscular blocking drugs. Med Toxicol Adverse Drug Exp 1989; 4:351-68
17. Naguib M, Lien CA: Pharmacology of muscle relaxants and their antagonists, Miller's Anesthesia. Edited by Miller RD. Philadelphia, Elsevier, 2005, pp 481-572
18. Papke RL, Porter Papke JK: Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis. Br J Pharmacol 2002; 137:49-61
19. Papke RL, Thinschmidt JS: The correction of alpha7 nicotinic acetylcholine receptor concentration-response relationships in Xenopus oocytes. Neurosci Lett 1998; 256:163-6
20. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC: Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 1997; 280:346-56
21. Garland CM, Foreman RC, Chad JE, Holden-Dye L, Walker RJ: The actions of muscle relaxants at nicotinic acetylcholine receptor isoforms. Eur J Pharmacol 1998; 357:83-92
22. Hatton CJ, Shelley C, Brydson M, Beeson D, Colquhoun D: Properties of the human muscle nicotinic receptor, and of the slow-channel myasthenic syndrome mutant epsilonL221F, inferred from maximum likelihood fits. J Physiol 2003; 547:729-60
23. Placzek AN, Grassi F, Papke T, Meyer EM, Papke RL: A single point mutation confers properties of the muscle-type nicotinic acetylcholine receptor to homomeric alpha7 receptors. Mol Pharmacol 2004; 66:169-77
24. Yost CS, Winegar BD: Potency of agonists and competitive antagonists on adult- and fetal-type nicotinic acetylcholine receptors. Cell Mol Neurobiol 1997; 17:35-50
25. Marshall CG, Ogden DC, Colquhoun D: The actions of suxamethonium (succinyldicholine) as an agonist and channel blocker at the nicotinic receptor of frog muscle. J Physiol 1990; 428:155-74
26. Peng X, Katz M, Gerzanich V, Anand R, Lindstrom J: Human alpha 7 acetylcholine receptor: Cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. Mol Pharmacol 1994; 45:546-54
27. Anand R, Conroy WG, Schoepfer R, Whiting P, Lindstrom J: Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. J Biol Chem 1991; 266:11192-8
28. Cooper E, Couturier S, Ballivet M: Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 1991; 350:235-8
29. Boorman JP, Groot-Kormelink PJ, Sivilotti LG: Stoichiometry of human recombinant neuronal nicotinic receptors containing the b3 subunit expressed in Xenopus oocytes. J Physiol 2000; 529(pt 3): 565-77.
30. Zwart R, Vijverberg HP: Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Mol Pharmacol 1998; 54:1124-31
31. Nelson ME, Kuryatov A, Choi CH, Zhou Y, Lindstrom J: Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors. Mol Pharmacol 2003; 63:332-41
32. Chiodini F, Charpantier E, Muller D, Tassonyi E, Fuchs-Buder T, Bertrand D: Blockade and activation of the human neuronal nicotinic acetylcholine receptors by atracurium and laudanosine. ANESTHESIOLOGY 2001; 94:643-51
33. Bowman WC: Block by depolarization. Acta Anaesthesiol Scand 1994; 38:529-32
34. Roy JJ, Donati F, Boismenu D, Varin F: Concentration-effect relation of succinylcholine chloride during propofol anesthesia. ANESTHESIOLOGY 2002; 97: 1082-92
35. Fortier LP, Robitaille R, Donati F: Increased sensitivity to depolarization and nondepolarizing neuromuscular blocking agents in young rat hemidiaphragms. ANESTHESIOLOGY 2001; 95:478-84
36. Tuba Z, Maho S, Vizi ES: Synthesis and structure-activity relationships of neuromuscular blocking agents. Curr Med Chem 2002; 9:1507-36
37. Ali HH, Utting JE, Gray C: Stimulus frequency in the detection of neuromuscular block in humans. Br J Anaesth 1970; 42:967-78
38. Lee C: Dose relationships of phase II, tachyphylaxis and train-of-four fade in suxamethonium-induced dual neuromuscular block in man. Br J Anaesth 1975; 47:841-5
39. Lee C, Katz RL: Neuromuscular pharmacology: A clinical update and commentary. Br J Anaesth 1980; 52:173-88
40. Timoteo MA, Faria M, Correia-de-Sa PM: Endogenous adenosine prevents post-tetanic release facilitation mediated by alpha3beta2 nicotinic autoreceptors. Eur J Pharmacol 2003; 464:115-25
41. Prior C, Tian L, Dempster J, Marshall IG: Prejunctional actions of muscle relaxants: Synaptic vesicles and transmitter mobilization as sites of action. Gen Pharmacol 1995; 26:659-66
42. Lee C: Conformation, action, and mechanism of action of neuromuscular blocking muscle relaxants. Pharmacol Ther 2003; 98:143-69
43. Papke RL, Bencherif M, Lippiello P: An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype. Neurosci Lett 1996; 213:201-4
44. Alkondon M, Pereira EF, Cortes WS, Maelicke A, Albuquerque EX: Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons. Eur J Neurosci 1997; 9:2734-42
45. Fuentealba J, Olivares R, Ales E, Tapia L, Rojo J, Arroyo G, Aldea M, Criado M, Gandia L, Garcia AG: A choline-evoked [Ca2+]c signal causes catecholamine release and hyperpolarization of chromaffin cells. FASEB J 2004; 18:1468-70
46. Hou VY, Hirshman CA, Emala CW: Neuromuscular relaxants as antagonists for M2 and M3 muscarinic receptors. ANESTHESIOLOGY 1998; 88:744-50
47. Lanier WL, Milde JH, Michenfelder JD: Cerebral stimulation following succinylcholine in dogs. ANESTHESIOLOGY 1986; 64:551-9
48. Brunner MD, Nathwani D, Rich PA, Thornton C, Dore CJ, Newton DE: Effect of suxamethonium on the auditory evoked response in humans. Br J Anaesth 1996; 76:34-7
49. Oshima E, Shingu K, Mori K: E.E.G. activity during halothane anaesthesia in man. Br J Anaesth 1981; 53:65-72